ARCHIVES

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

This article is from The Cancer Letter archive.

Vol. 03 No. 03 | January 21, 1977

Download PDF Visit The Full Archive

Related Articles

Bladder Cancer Survival Rate Rises With Neoadjuvant Chemo

September 26, 2003

Proposed Guidelines For Clinical Tests Of Oncologic Drugs

November 28, 1975

Waksal Pleads Guilty To Securities Fraud

October 18, 2002

Researchers Feel Impact of Shutdown As Grant Review Stops, Funding Runs Dry

January 5, 1996

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

June 23, 1995

In Brief: Senate Markup adds $22 Mil. To NCI Budget; Roper formally Named NCI Deputy Director

September 22, 1989